In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors

被引:0
|
作者
M. Asadollahi-Baboli
机构
[1] Babol University of Technology,Department of Science
来源
Molecular Diversity | 2016年 / 20卷
关键词
Quinazolines; Molecular docking; GA-ANN; MARS; EGFR; Descriptor selection;
D O I
暂无
中图分类号
学科分类号
摘要
Mutated epidermal growth factor receptor (EGFR-T790M) inhibitors hold promise as new agents against cancer. Molecular docking and QSAR analysis were performed based on a series of fifty-three quinazoline derivatives to elucidate key structural and physicochemical properties affecting inhibitory activity. Molecular docking analysis identified the true conformations of ligands in the receptor’s active pocket. The structural features of the ligands, expressed as molecular descriptors, were derived from the obtained docked conformations. Non-linear and spline QSAR models were developed through novel genetic algorithm and artificial neural network (GA-ANN) and multivariate adaptive regression spline techniques, respectively. The former technique was employed to consider non-linear relation between molecular descriptors and inhibitory activity of quinazoline derivatives. The later technique was also used to describe the non-linearity using basis functions and sub-region equations for each descriptor. Our QSAR model gave a high predictive performance (Rp2=0.881,QLOO2=0.923,RLSO2=0.828\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$(R_{\mathrm{p}}^{2}=0.881, Q_{\mathrm{LOO}}^{2}=0.923, R^{2}_{\mathrm{LSO}}=0.828$$\end{document} and rm2=0.772\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$r_{\mathrm{m}}^{2}=0.772$$\end{document}) using diverse validation techniques. Eight new compounds were designed using our QSAR model as potent EGFR-T790M inhibitors. Overall, the proposed in silico strategy based on docked derived descriptor and non-linear descriptor subset selection may help design novel quinazoline derivatives with improved EGFR-T790M inhibitory activity.
引用
收藏
页码:729 / 739
页数:10
相关论文
共 50 条
  • [31] Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening
    Ornnork, Narittira
    Kiriwan, Duangnapa
    Lirdprapamongkol, Kriengsak
    Choowongkomon, Kiattawee
    Svasti, Jisnuson
    Eurtivong, Chatchakorn
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2020, 99 (99):
  • [32] The Diagnostic Accuracy of Circulating Tumor DNA for the Detection of EGFR-T790M Mutation in NSCLC: A Systematic Review and Meta-Analysis
    Passiglia, F.
    Di Maio, M.
    Rizzo, S.
    Galvano, A.
    Badalamenti, G.
    Listi, A.
    Barraco, N.
    Incorvaia, L.
    Castiglia, M.
    Bazan, V.
    Russo, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S588 - S588
  • [33] The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
    Francesco Passiglia
    Sergio Rizzo
    Massimo Di Maio
    Antonio Galvano
    Giuseppe Badalamenti
    Angela Listì
    Leonardo Gulotta
    Marta Castiglia
    Fabio Fulfaro
    Viviana Bazan
    Antonio Russo
    Scientific Reports, 8
  • [34] In silico Exploration of Quinazolinone-incorporated-chalcones as EGFR inhibitors (T790M mutated) to Combat Lung Cancer
    Arora, Praveen Kumar
    Kumar, Sushil
    Bansal, Sandeep Kumar
    Virmani, Tarun
    ORIENTAL JOURNAL OF CHEMISTRY, 2024, 40 (05) : 1382 - 1393
  • [35] In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions
    Hanwarinroj, Chayanin
    Thongdee, Paptawan
    Sukchit, Darunee
    Taveepanich, Somjintana
    Kamsri, Pharit
    Punkvang, Auradee
    Ketrat, Sombat
    Saparpakorn, Patchreenart
    Hannongbua, Supa
    Suttisintong, Khomson
    Kittakoop, Prasat
    Spencer, James
    Mulholland, Adrian J.
    Pungpo, Pornpan
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 115
  • [36] Identification of the structural features of quinazoline derivatives as EGFR inhibitors using 3D-QSAR modeling, molecular docking, molecular dynamics simulations and free energy calculations
    Wang, Fangfang
    Yang, Wei
    Liu, Hongping
    Zhou, Bo
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (21): : 11125 - 11140
  • [37] Development of an efficient scoring system for detection of EGFR-T790M mutation in non-small cell lung cancer patients treated with EGFR-tyrosine kinase inhibitors.
    Kawamura, Takahisa
    Kenmotsu, Hirotsugu
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Mori, Keita
    Ohde, Yasuhisa
    Endo, Masahiro
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Molecular dynamics and pharmacophore modelling studies of different subtype (ALK and EGFR (T790M)) inhibitors in NSCLC
    Singh, P. K.
    Silakari, O.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2017, 28 (03) : 221 - 233
  • [39] Design and evaluation of sulfadiazine derivatives as potent dual inhibitors of EGFRWT and EGFRT790M: integrating biological, molecular docking, and ADMET analysis
    Abd El-Lateef, Hany M.
    Ezelarab, Hend A. A.
    Ali, Ali M.
    Alsaggaf, Azhaar T.
    Mahdi, Wael A.
    Alshehri, Sultan
    El Hamd, Mohamed A.
    Aboelez, Moustafa O.
    RSC ADVANCES, 2024, 14 (39) : 28608 - 28625
  • [40] In silico screening of Fyn kinase inhibitors using classification-based QSAR model, molecular docking, molecular dynamics and ADME study
    Hang, Nguyen Thu
    Anh, Thai Doan Hoang
    Thanh, Le Nguyen
    Anh, Nguyen Viet
    Phuong, Nguyen Van
    MOLECULAR DIVERSITY, 2024, 28 (04) : 2217 - 2228